Diffusion of Extended-Spectrum and Plasmid-Mediated Amp-C β-Lactamase Producing <em>Proteus mirabilis </em>in Hospitals and Community Setting in Zagreb, Croatia, First Report of CTX-M-32 and CTX-M-101 in <em>Proteus mirabilis</em>

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background/Objectives: Proteus mirabilis is a frequent causative agent of urinary tract and wound infections in community and hospital settings. It develops re-sistance to expanded-spectrum cephalosporins (ESC) due to the production of ex-tended-spectrum &beta;-lactamases (ESBLs) or plasmid-mediated AmpC &beta;-lactamases (p-AmpC). During routine microbiology testing, we observed an increased rate of multi-drug-resistant (MDR) P. mirabilis isolates. Here, we report the characteristics of ESBLs and p-AmpC &beta;-lactamases encountered among hospital and community isolates of P. mirabilis in two hospitals and the community settings in Zagreb, Croatia. Methods: Antibiotic susceptibility testing was performed by disk-diffusion and broth dilution methods. The double disk synergy test (DDST) and inhibitor-based test with clavulanic and cloxacillin were applied to screen for ESBLs and p-AmpC, respec-tively. PCR investigated the nature of ESBL, carbapenemases, and fluoroquinolone resistance determinants. Selected strains were subjected to molecular analysis of resistance traits by the Inter-array CarbaResist Kit and whole genome sequencing (WGS). Results: In total, 39 isolates were analyzed. Twenty-two isolates phenotypically tested positive for p-AmpC and seventeen for ESBLs. AmpC-producing organisms exhibited uniform resistance to amoxicillin-clavulanate, ESC, ciprofloxacin, and co-trimoxazole and uniform susceptibility to carbapenems and piperacillin-tazobactam and harbored blaCMY-16 genes. ESBL-positive isolates demonstrated resistance to amoxicillin-clavulanate, cefuroxime, cefotaxime, ceftriaxone, and ciprofloxacin, but variable susceptibility to cefepime and aminoglycosides. They possessed blaCTX-M genes that belong to cluster 1 (n=5) or 9 (n=12) with CTX-M-14 as the dominant allelic variant. Conclusions: The study's main finding is the diffusion of CTX-M ESBL and CMY-16 p-AmpC among hospital and community-acquired isolates. AmpC-producing iso-lates showed uniform resistance patterns, whereas ESBL-positive strains had varia-ble degrees of susceptibility/resistance to non-&beta;-lactam antibiotics, resulting in more diverse susceptibility patterns. The study demonstrated diffusion resistance deter-minants among hospital and outpatient isolates, mandating improvement in de-tecting &beta;-lactamases during routine laboratory work.

Article activity feed